What one share of Kura Oncology holds
We are a biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Since our founding in 2014, we have transformed from a research and development company to a fully-integrated commercial-stage organization with a diversified pipeline of product candidates.
Kura Oncology’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.87 |
|---|---|
| Profit | −$3.36 |
| Capex (buildings and equipment) | $0.06 |
| Free cash flow | −$1.33 |
| Cash and investments | $0.79 |
| Debt | $0.11 |
| Book value | $0.54 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2011 | — | −$0.01 | — | — | — | −$0.01 |
| 2012 | — | −$0.01 | — | — | — | −$0.02 |
| 2013 | — | −$0.01 | — | — | — | −$0.02 |
| 2014 | — | −$0.01 | — | — | — | — |
| 2015 | — | −$2.28 | $0.01 | −$1.81 | — | $4.53 |
| 2016 | — | −$1.47 | — | — | — | $2.94 |
| 2017 | — | −$1.52 | — | — | — | $2.71 |
| 2018 | — | −$1.72 | — | — | — | $4.22 |
| 2019 | — | −$1.51 | — | — | — | $4.82 |
| 2020 | — | −$1.69 | $0.04 | −$1.36 | — | $9.23 |
| 2021 | — | −$1.97 | $0.02 | −$1.59 | — | $7.61 |
| 2022 | — | −$2.03 | $0.01 | −$1.65 | — | $6.15 |
| 2023 | $0.00 | −$2.08 | $0.00 | −$1.71 | — | $5.34 |
| 2024 | $0.63 | −$2.02 | $0.01 | $1.55 | — | $5.29 |
| 2025 | $0.77 | −$3.18 | $0.08 | −$0.81 | — | $1.98 |
Common questions about Kura Oncology
How much does one share of Kura Oncology earn?
Over the last 12 months, Kura Oncology lost $3.36 for each share on $0.87 of sales.
Does Kura Oncology pay a dividend?
Kura Oncology didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Kura Oncology’s book value per share?
Kura Oncology’s book value is $0.54 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Kura Oncology have?
Each share of Kura Oncology has $0.79 of cash and investments and $0.11 of debt, as of June 30, 2026.
What is Kura Oncology’s free cash flow per share?
−$1.33 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Kura Oncology bought back shares?
Kura Oncology’s share count rose about 1654% from 2011 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.